The effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment

ISRCTN ISRCTN08045231
DOI https://doi.org/10.1186/ISRCTN08045231
ClinicalTrials.gov number NCT00689975
Secondary identifying numbers 05A008
Submission date
24/08/2005
Registration date
25/10/2005
Last edited
24/01/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

http://cancerhelp.cancerresearchuk.org/trials/a-trial-looking-at-the-effect-of-exercise-and-dietary-changes-for-women-recovering-from-breast-cancer-treatment

Contact information

Dr John Saxton
Scientific

Centre for Sport and Exercise Science
Sheffield Hallam University
Collegiate Crescent Campus
Sheffield
S10 2BP
United Kingdom

Phone +44 (0)114 225 4414
Email j.m.saxton@shu.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment
Study objectives1. A dietary and exercise intervention will evoke a reduction in body weight in overweight or obese women who have undergone breast cancer treatment
2. A dietary and exercise intervention will evoke positive changes in indices of psychological health status and biomarkers associated with disease recurrence in overweight or obese women who have undergone breast cancer treatment
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBreast cancer
InterventionExercise and dietary intervention versus no intervention.
Intervention typeOther
Primary outcome measureBody weight; body composition.
Secondary outcome measuresPsychological health status; biomarkers associated with disease recurrence (including stress hormones, immune function, inflammatory mediators); quality of life; cardiovascular fitness.
Overall study start date01/10/2005
Completion date30/09/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants100
Key inclusion criteria1. Women who have undergone appropriate treatment for operable breast cancer within the past 3-18 months and are no longer undergoing chemotherapy or radiation therapy, will be recruited from the Cancer Research Centre, Weston Park Hospital, Sheffield University Hospitals NHS Trust
2. Postmenopausal women (confirmed by plasma estradiol and gonadotrophin measures in all women aged <55) with a body mass index (BMI) >25 and classified as disease stage I-III
3. Patients must have completed some form of breast cancer treatment at least three months, and not more than 18 months ago
4. Patients on Tamoxifen and other endocrine treatments but not hormone replacement therapy (HRT) will be included
5. Patients must be willing and able to attend supervised exercise sessions at least 3 times per week for a period of 24 weeks, with the intention of achieving an 80% minimum compliance target for attendance
6. Patients must be an exercise pre-contemplator, contemplator or preparer as defined by the Transtheoretical Model
Key exclusion criteria1. Metastatic breast cancer patients and patients with inoperable or active loco-regional disease
2. Patients following alternative/complementary diets or taking high dose antioxidant supplements
3. Patients with a physical/psychiatric impairment that would seriously impair their physical mobility
4. Patients who are currently suffering from severe nausea, anorexia or other diseases affecting health (e.g. arthritis and multiple sclerosis)
5. HRT is not commonly prescribed in women who are recovering from breast cancer treatment, but use of HRT or oral contraceptives within the past four months is an exclusion criteria
6. Patients who are currently engaged in exercise (two or more times per week for at least 30 min per session during the previous 3 months)
Date of first enrolment01/10/2005
Date of final enrolment30/09/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Centre for Sport and Exercise Science
Sheffield
S10 2BP
United Kingdom

Sponsor information

Sheffield Hallam University (UK)
University/education

City Campus
Howard Street
Sheffield
S1 1WB
England
United Kingdom

Phone +44 (0)114 225 5555
Email liaison@shu.ac.uk
Website http://www.shu.ac.uk
ROR logo "ROR" https://ror.org/019wt1929

Funders

Funder type

Research organisation

American Institute for Cancer Research (USA) (ref: 05A008)
Government organisation / Research institutes and centers
Alternative name(s)
American Institute for Cancer Research, Inc., AICR
Location
United States of America

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 09/02/2006 Yes No
Results article results 01/01/2013 Yes No
Results article results 14/04/2014 Yes No
Plain English results 24/01/2022 No Yes

Editorial Notes

24/01/2022: A link to plain English results was added.